Centrexion Therapeutics logo
Centrexion Therapeutics logo

Centrexion Therapeutics

centrexion.com
centrexion.com · HQ: Boston, United States · Debt Financing 2023 · Startup
HQ: Boston, United States · Debt Financing 2023 · Startup
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$125.4M
10 rounds on record
Latest round
$69.6M
Venture round · Dec 2017 · 8 yr ago
Backers
1
NEA
The money's age
Long since its last round
106 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 14, 2023 Took on debt financing $2.3M · SEC Form D Jun 14, 2023 Took on debt financing $10.3M · SEC Form D May 24, 2022 Took on debt financing $29.1M · SEC Form D Jan 12, 2021 Took on debt financing $13.5M · SEC Form D Dec 18, 2017 Raised a round Venture round $69.6M · SEC Form D Apr 28, 2017 Raised a round Convertible Note $5.3M · SEC Form D Dec 30, 2016 Raised a round Venture round $16.6M · SEC Form D Mar 1, 2016 Raised a round Convertible Note $10.5M · SEC Form D Nov 20, 2013 Raised a round Venture round $8.8M · SEC Form D Nov 20, 2013 Raised a round Venture round $14.7M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Debt Financing Nov 2023 $2.3M — SEC Form D
Debt Financing Jun 2023 $10.3M — SEC Form D
Debt Financing May 2022 $29.1M — SEC Form D
Debt Financing Jan 2021 $13.5M — SEC Form D
Venture round Dec 2017 $69.6M — SEC Form D
Convertible Note Apr 2017 $5.3M — SEC Form D
Venture round Dec 2016 $16.6M — SEC Form D
Convertible Note Mar 2016 $10.5M — SEC Form D
Venture round Nov 2013 $14.7M — SEC Form D
Venture round Nov 2013 $8.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Centrexion Therapeutics Corp SEC Form D
Founders and leadersfrom filings, registers and the company's site
Jeffrey KindlerExecutive Officer, DirectorSEC Form D
James Campbell M.D.Executive Officer, DirectorSEC Form D
Randall StevensExecutive OfficerSEC Form D
Michael WardExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
NEA fund
Investors in similar startupsfunds that back the companies most like this one
Plug and Play
backs Bahto Biosciences
Techstars
backs Nerveli
Fusion Fund
backs Blumind
SJF Ventures
backs groSolar
Real Ventures
backs Blumind
ACME Capital
backs Blumind
Similar startupsby what they do, their industry and backers
Red Ridge Bio
At RedRidge, we are leaders in the identification and development of biparatopic antibodies, designed to deliver exceptional efficacy…
BlumindSeries A · 18 mo ago · Founded 2020
Enabling Edge AI with Analog Compute Technology Blumind is a Canadian deep-tech startup... ...led by industry visionaries with a proven…
rebel medicine logoVenture round $8.8M · 20 mo ago · Founded 2020 · 11-50 employees
Revolutionizing acute pain management. Rebel is focused on developing disruptive, non-opioid solutions for acute pain.
HoloMemVenture round · 2 mo ago · Founded 2020
0 About Us HoloMem was founded in 2020 by a team of holographers and innovators with a proven track record of developing and delivering…
groSolar201-500 employees
GroSolar. groSolar's design-build and project management team is one of the most experienced in the solar industry. We have a proven track…
NerveliVenture round $430k · 13 mo ago · Founded 2022
A personalized, science-based pain relief app that makes managing chronic pain simple. Track symptoms, get CBT-informed support, and find…

Overview

Solving unmet needs with a proven track record. We’re a dynamic company led by experienced leaders in the industry who are strategically building a portfolio with powerful opportunities in two emerging and growing categories: non-opioid pain relief and immunology.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
NEAVia a fund
673 portfolio companies
Report a mistake

People

Jeffrey Kindler
Executive Officer, Director
SEC Form D
James Campbell M.D.
Executive Officer, Director
SEC Form D
Randall Stevens
Executive Officer
SEC Form D
Michael Ward
Executive Officer
SEC Form D
Sol Barer Ph.D.
Director
SEC Form D
Colin Hill
Director
SEC Form D
J.c. Lopez M.D.
Director
SEC Form D
Joseph Swedish
Director
SEC Form D
Shawn Tomasello
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston United States
HQ
Our Location
Suite 3520, Boston, MA 02108
company site

Financials

Total raised
$180.6M
Latest round
Debt Financing
Funding rounds
10
Funding rounds
Round Announced Amount
Debt Financing 2023 $2.3M Details
Debt Financing 2023 $10.3M Details
Debt Financing 2022 $29.1M Details
Debt Financing 2021 $13.5M Details
Venture - Series Unknown 2017 $69.6M Details
Convertible Note 2017 $5.3M Details
Venture - Series Unknown 2016 $16.6M Details
Convertible Note 2016 $10.5M Details
Venture - Series Unknown 2013 $14.7M Details
Venture - Series Unknown 2013 $8.8M Details